Effects of dietary milk- and soy phospholipids on lipid-parameters and other risk indicators for cardiovascular diseases in overweight or obese men : two double-blind, randomised, controlled, clinical trials

Autor: Achim Bub, Maria Pfeuffer, Juergen Schrezenmeir, Anne Weiland, Stephan Barth
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
Apolipoprotein B
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
soya phospholipids
Overweight
PC
phosphatidylcholine

fluids and secretions
AST
aspartate transaminase

ddc:796
Nutrition and Dietetics
biology
Fatty liver
food and beverages
CVD
PL
phospholipid

Athletic & outdoor sports & games
CRP
C-reactive protein

lipids (amino acids
peptides
and proteins)

medicine.symptom
MTHFR
methylenetetrahydrofolate reductase

Research Article
medicine.medical_specialty
Waist
milk phospholipids
ALT
alanine transaminase

Aspartate transaminase
HOMA-IR
homeostasis model assessment of insulin resistance

tHcy
total homocysteine

03 medical and health sciences
GGT
γ-glutamyl transferase

Internal medicine
plasma lipids
medicine
human nutrition
030109 nutrition & dietetics
SM
sphingomyelin

business.industry
Insulin
HDL-C
HDL-cholesterol

C-reactive protein
MFGM
milk fat globule membrane

LDL-C
LDL-cholesterol

medicine.disease
TC
total cholesterol

Endocrinology
Alanine transaminase
biology.protein
business
Food Science
Zdroj: Journal of nutritional science, 5 (e21), 1-9
Journal of Nutritional Science
ISSN: 2048-6790
Popis: The present study examined the effect of milk phospholipids (milk-PL) on lipid metabolism and on other risk factors for CVD, in comparison with milk fat (control) or soya phospholipids (soya-PL), respectively. Two double-blind parallel-group intervention trials were conducted in overweight or obese male subjects. In the first trial (trial 1), sixty-two men consumed milk enriched with either 2 g milk-PL or 2 g milk fat (control) for 8 weeks. In trial 2, fifty-seven men consumed milk enriched with either 3 g milk-PL or 2·8 g soya-PL for 7 weeks. In trial 1, milk-PL as compared with control reduced waist circumference but did not affect plasma lipids (total, HDL- and LDL-cholesterol, total cholesterol:HDL-cholesterol ratio, TAG, phospholipids), apoB, apoA1, glucose, insulin, insulin sensitivity index, C-reactive protein, IL-6, soluble intracellular adhesion molecule and total homocysteine (tHcy). Serum activities of alanine transaminase and aspartate transaminase were not changed. Activity of γ-glutamyl transferase (GGT), a marker of fatty liver, increased in the control but not in the milk-PL group, with a significant intervention effect. In trial 2, milk-PL as compared with soya-PL did not affect the above-mentioned parameters, but decreased GGT. Subjects with the methylenetetrahydrofolate reductase mutations CT and TT had 11 % (P
Databáze: OpenAIRE